The transformative impact of AI-enabled AlphaFold 3: evolution, current status, and future prospects in structural...

Area of Science:

• Structural biology
• Artificial intelligence in life sciences
• Computational biology

Background:

• The AlphaFold initiative has significantly advanced protein structure prediction, culminating in a Nobel Prize.
• Progress from AlphaFold 1 (AF1) to AlphaFold 3 (AF3) has expanded predictive capabilities from single proteins to complex molecular assemblies.

Purpose of the Study:

• To review the architectural evolution of AlphaFold models (AF1, AF2, AF3).
• To explore the impact of AlphaFold on structural biology, translational research, and drug discovery.
• To discuss current limitations and future directions for protein structure prediction.

Main Methods:

• AlphaFold 1 (AF1) utilizes deep neural networks (DNNs).
• AlphaFold 2 (AF2) incorporates the Evoformer architecture for analyzing evolutionary sequence data.
• AlphaFold 3 (AF3) employs the Pairformer for modeling amino acid interactions within complexes.

Main Results:

• AlphaFold 2 achieved near-experimental accuracy for single-chain protein folding.
• AlphaFold 3 extends predictions to protein-ligand, protein-nucleic acid, and protein-protein interactions.
• Widespread adoption of AlphaFold tools and the AlphaFold Database (AFDB) has increased accessibility and accelerated research.

Conclusions:

• AlphaFold's evolution has dramatically expanded structural coverage and accessibility, driving innovation in structure-based drug discovery and macromolecular assembly studies.
• Despite challenges in predicting protein dynamics and conformational states, AlphaFold is set to further advance biotechnology and medicine.